Evotec has signed an agreement with Vifor Pharma to provide and project-manage the discovery activities to identify a preclinical candidate for the treatment of anaemia.
The agreement applies Evotec's integrated drug discovery expertise and technologies to progress novel small molecules for the treatment of anaemia from discovery into lead optimisation.
Evotec will use scientists based at both its European and Indian sites covering in vitro biology, medicinal chemistry, in vitro and in vivo pharmacology and the programme will be funded through research funding and success-based milestones.
